From needles to pills: oral GLP-1 therapy enters the obesity arena
Crossref DOI link: https://doi.org/10.1186/s40842-025-00245-5
Published Online: 2025-10-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Santulli, Gaetano
Text and Data Mining valid from 2025-10-06
Version of Record valid from 2025-10-06
Article History
First Online: 6 October 2025
Declarations
:
: Not applicable.
: Prof. Santulli is the Editor-in-Chief of Cardiovascular Diabetology - Endocrinology Reports.